These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6251327)

  • 21. Catecholamines and neurologic diseases (second of two parts).
    Moskowitz MA; Wurtman RJ
    N Engl J Med; 1975 Aug; 293(7):332-8. PubMed ID: 125386
    [No Abstract]   [Full Text] [Related]  

  • 22. Brain neurotransmitter receptors after long-term haloperidol: dopamine, acetylcholine, serotonin, alpha-noradrenergic and naloxone receptors.
    Muller P; Seeman P
    Life Sci; 1977 Dec; 21(12):1751-8. PubMed ID: 203807
    [No Abstract]   [Full Text] [Related]  

  • 23. Quantitative autoradiography of neurotransmitter receptors in Huntington disease.
    Penney JB; Young AB
    Neurology; 1982 Dec; 32(12):1391-5. PubMed ID: 6292789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isolation and characterization of membrane drug receptors.
    Gourley DR
    Prog Drug Res; 1976; 20():323-46. PubMed ID: 189353
    [No Abstract]   [Full Text] [Related]  

  • 25. Stress, endorphins and psychosis. A hypothesis.
    Amir S; Amit Z; Brown ZW
    Mod Probl Pharmacopsychiatry; 1981; 17():192-201. PubMed ID: 6276725
    [No Abstract]   [Full Text] [Related]  

  • 26. Biochemical characterization of the muscarinic cholinergic receptor in human brain: alterations in Huntington's disease.
    Wastek GJ; Yamamura HI
    Mol Pharmacol; 1978 Sep; 14(5):768-80. PubMed ID: 152407
    [No Abstract]   [Full Text] [Related]  

  • 27. Cholinergic circuits and signaling in the pathophysiology of schizophrenia.
    Berman JA; Talmage DA; Role LW
    Int Rev Neurobiol; 2007; 78():193-223. PubMed ID: 17349862
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Somatostatin alterations and brain diseases.
    Epelbaum J; Agid Y; Enjalbert A; Hamon M; Javoy-Agid F; Kordon C; Lamour Y; Moyse E
    Adv Exp Med Biol; 1985; 188():261-74. PubMed ID: 2863935
    [No Abstract]   [Full Text] [Related]  

  • 29. [Endorphins and endogenous psychoses].
    Naber D; Pickar D
    Nervenarzt; 1984 Jul; 55(7):378-81. PubMed ID: 6089011
    [No Abstract]   [Full Text] [Related]  

  • 30. Stereoselective muscarinic acetylcholine and opiate receptiors in human phagocytic leukocytes.
    Lopker A; Abood LG; Hoss W; Lionetti FJ
    Biochem Pharmacol; 1980 May; 29(10):1361-5. PubMed ID: 6249313
    [No Abstract]   [Full Text] [Related]  

  • 31. [The role of GABA neurons in some neurological and psychiatric disorders (author's transl)].
    Pericić D
    Lijec Vjesn; 1979 Sep; 101(9):541-6. PubMed ID: 161601
    [No Abstract]   [Full Text] [Related]  

  • 32. [Dementia and psychotic disorders in parkinsonism: common origin and new perspectives in therapy].
    Litvinenko IV
    Adv Gerontol; 2004; 13():94-101. PubMed ID: 15490731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alterations in the benzodiazepine receptor of Huntington's diseased human brain.
    Reisine TD; Wastek GJ; Speth RC; Bird ED; Yamamura HI
    Brain Res; 1979 Apr; 165(1):183-7. PubMed ID: 34467
    [No Abstract]   [Full Text] [Related]  

  • 34. Receptor occupancy dose--response curve suggests that phosphatidyl-inositol breakdown may be intrinsic to the mechanism of the muscarinic cholinergic receptor.
    Michell RH; Jafferji SS; Jones LM
    FEBS Lett; 1976 Oct; 69(1):1-5. PubMed ID: 992019
    [No Abstract]   [Full Text] [Related]  

  • 35. Neurotransmitter receptor alterations in Parkinson's disease.
    Reisine TD; Fields JZ; Yamamura HI
    Life Sci; 1977 Aug; 21(3):335-43. PubMed ID: 197361
    [No Abstract]   [Full Text] [Related]  

  • 36. Neurology and psychopharmacology.
    Merskey H
    Mod Trends Neurol; 1975; 6():241-7. PubMed ID: 127928
    [No Abstract]   [Full Text] [Related]  

  • 37. Interaction of phencyclidines with the muscarinic and opiate receptors in the central nervous system.
    Vincent JP; Cavey D; Kamenka JM; Geneste P; Lazdunski M
    Brain Res; 1978 Aug; 152(1):176-82. PubMed ID: 79434
    [No Abstract]   [Full Text] [Related]  

  • 38. Histochemistry of receptors.
    Young WS; Palacios JM; Kuhar MJ
    Adv Biochem Psychopharmacol; 1980; 21():51-6. PubMed ID: 6246758
    [No Abstract]   [Full Text] [Related]  

  • 39. Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's, and Huntington's diseases.
    Seeman P; Bzowej NH; Guan HC; Bergeron C; Reynolds GP; Bird ED; Riederer P; Jellinger K; Tourtellotte WW
    Neuropsychopharmacology; 1987 Dec; 1(1):5-15. PubMed ID: 2908095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of vitamin D on brain development and adult brain function.
    Kesby JP; Eyles DW; Burne TH; McGrath JJ
    Mol Cell Endocrinol; 2011 Dec; 347(1-2):121-7. PubMed ID: 21664231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.